Marburg Virus: Why Rare Deadly Viruses Need Vaccine Preparedness

Marburg virus disease is a severe illness caused by Marburg virus, a filovirus related to Ebola virus. It can cause high fever, severe weakness, vomiting, diarrhea, bleeding, shock, and organ failure. WHO notes that the average case fatality rate is around 50%, though past outbreaks have varied widely depending on virus strain and quality of care.

Marburg outbreaks often begin with zoonotic spillover, meaning the virus moves from animals to humans. Fruit bats are considered a natural reservoir. After spillover, the virus can spread between people through direct contact with blood, bodily fluids, contaminated surfaces, or unsafe burial practices. Health-care workers are at particular risk when infection prevention and control systems are not strong.

Ethiopia’s first Marburg outbreak, which ended in January 2026, showed both the danger and the value of rapid response. WHO reported 19 cumulative cases, including 14 confirmed and 5 probable cases, and the outbreak was declared over after 42 days without a new confirmed case.

There is no approved vaccine or antiviral treatment for Marburg virus disease. Supportive care—especially early rehydration, oxygen support, treatment of complications, and careful monitoring—can improve survival. Public health control depends on isolation, contact tracing, safe burial practices, laboratory confirmation, and protection of healthcare workers.

The vaccine field is advancing. IAVI launched a Phase 1 trial in April 2026 of rVSV∆G-MARV-GP, a single-dose investigational vaccine candidate. IAVI reports that preclinical studies showed strong protection in nonhuman primates after lethal Marburg virus challenge, but human safety and immunogenicity data are still needed.

Take-home message: Marburg virus may be rare, but rare does not mean unimportant. Vaccine preparedness for high-consequence pathogens protects local communities, healthcare workers, and global public health security.

Reference：https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease